Abstract
IntroductionReceptor Activator of NfκB-Ligand (RANKL) and Osteoprotegerin (OPG) play a key role in the pathogenesis of osteoporosis in rheumatic diseases. We have recently shown that autoantibodies against OPG (OPG ab)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
